Literature DB >> 16682721

Topoisomerase IIalpha gene amplification and response to anthracycline-containing adjuvant chemotherapy in breast cancer.

Aman U Buzdar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16682721     DOI： 10.1200/JCO.2006.05.9113

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.

Authors:  Raymond Tubbs; William E Barlow; G Thomas Budd; Eric Swain; Peggy Porter; Allen Gown; I-Ten Yeh; George Sledge; Charles Shapiro; James Ingle; Charles Haskell; Kathy S Albain; Robert Livingston; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2009-07-20       Impact factor: 44.544

2.  A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer.

Authors:  Xin Yao; Janet Hosenpud; Christopher R Chitambar; John Charlson; Yee Chung Cheng
Journal:  J Cancer       Date:  2012-04-01       Impact factor: 4.207

3.  Practical consensus recommendations on management of HR + ve early breast cancer with specific reference to genomic profiling.

Authors:  S Aggarwal; A Vaid; A Ramesh; Purvish M Parikh; S Purohit; B Avasthi; S Gupta; S Ranjan; V Kaushal; S Salim; R Singh; S Minhas; D Doval
Journal:  South Asian J Cancer       Date:  2018 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.